{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:17:23Z","timestamp":1708993043956},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,26]]},"DOI":"10.7759\/cureus.54935","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T12:40:28Z","timestamp":1708951228000},"source":"Crossref","is-referenced-by-count":0,"title":["Survivorship Struggles: Navigating Etiologies and Clinical Parameters of Febrile Neutropenia During Induction Chemotherapy in Acute Leukemia Patients"],"prefix":"10.7759","author":[{"given":"Muhammad Haris","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Adnan","family":"Wattoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habib ur Rehman","family":"Butt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umair","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehwish","family":"Kaneez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usaid","family":"Munir Joyia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Faheem","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2022.100296","article-title":"Clinical factors predictive of recurrent febrile neutropenia in adult patients with acute leukemia","volume":"17","author":"Wanitpongpun C","year":"2022","unstructured":"Wanitpongpun C, Teawtrakul N, Lanamtieng T, Chansung K, Sirijeerachai C, Amampai W, Sawanyawisuth K. Clinical factors predictive of recurrent febrile neutropenia in adult patients with acute leukemia. Leuk Res Rep. 2022, 17:100296. 10.1016\/j.lrr.2022.100296","journal-title":"Leuk Res Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8867760","article-title":"Early t-cell precursor leukemia has a higher risk of induction-related infection among t-cell acute lymphoblastic leukemia in adult","volume":"2020","author":"Huang K","year":"2020","unstructured":"Huang K, Dai M, Li Q, et al.. Early t-cell precursor leukemia has a higher risk of induction-related infection among t-cell acute lymphoblastic leukemia in adult. Mediators Inflamm. 2020, 2020:10.1155\/2020\/8867760","journal-title":"Mediators Inflamm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29940","article-title":"Outcomes of induction therapy in patients with acute myeloid leukemia during the COVID-19 pandemic: a retrospective study from a tertiary cancer center","volume":"14","author":"Iqbal A","year":"2022","unstructured":"Iqbal A, Daniel NR, Reddy R, Hazarika M, Deka R. Outcomes of induction therapy in patients with acute myeloid leukemia during the COVID-19 pandemic: a retrospective study from a tertiary cancer center. Cureus. 2022, 14:e29940. 10.7759\/cureus.29940","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.188","article-title":"Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012","volume":"30","author":"Dinmohamed AG","year":"2016","unstructured":"Dinmohamed AG, Visser O, van Norden Y, et al.. Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012. Leukemia. 2016, 30:24-31. 10.1038\/leu.2015.188","journal-title":"Leukemia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2013.310","article-title":"Incidence and management of infections in patients with acute leukemia following chemotherapy in general wards","volume":"7","author":"Biswal S","year":"2013","unstructured":"Biswal S, Godnaik C. Incidence and management of infections in patients with acute leukemia following chemotherapy in general wards. Ecancermedicalscience. 2013, 7:310. 10.3332\/ecancer.2013.310","journal-title":"Ecancermedicalscience"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2020.009","article-title":"Febrile neutropenia in acute leukemia. epidemiology, etiology, pathophysiology and treatment","volume":"12","author":"Hansen BA","year":"2020","unstructured":"Hansen BA, Wendelbo \u00d8, Bruserud \u00d8, Hemsing AL, Mosevoll KA, Reikvam H. Febrile neutropenia in acute leukemia. epidemiology, etiology, pathophysiology and treatment. Mediterr J Hematol Infect Dis. 2020, 12:e2020009. 10.4084\/MJHID.2020.009","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1820863","article-title":"Management of fever and neutropenia in the adult patient with acute myeloid leukemia","volume":"19","author":"Peseski AM","year":"2021","unstructured":"Peseski AM, McClean M, Green SD, Beeler C, Konig H. Management of fever and neutropenia in the adult patient with acute myeloid leukemia. Expert Rev Anti Infect Ther. 2021, 19:359-78. 10.1080\/14787210.2020.1820863","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20214413","article-title":"Incidence of neutropenic fever and sepsis in patients receiving induction chemotherapy in acute leukemia","volume":"9","author":"Sebastian P","year":"2021","unstructured":"Sebastian P, Kuruvadangal AM, Babu H. Incidence of neutropenic fever and sepsis in patients receiving induction chemotherapy in acute leukemia. Int J Res Med Sci. 2021, 9:3335. 10.18203\/2320-6012.ijrms20214413","journal-title":"Int J Res Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211036592","article-title":"The clinical profile, management, and outcome of febrile neutropenia in acute myeloid leukemia from resource constraint settings","volume":"8","author":"Mishra K","year":"2021","unstructured":"Mishra K, Kumar S, Ninawe S, et al.. The clinical profile, management, and outcome of febrile neutropenia in acute myeloid leukemia from resource constraint settings. Ther Adv Infect Dis. 2021, 8:20499361211036592. 10.1177\/20499361211036592","journal-title":"Ther Adv Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2017.18.10.2741","article-title":"Outcomes of high risk patients with febrile neutropenia at a tertiary care center","volume":"18","author":"Osmani AH","year":"2017","unstructured":"Osmani AH, Jabbar AA, Gangwani MK, Hassan B. Outcomes of high risk patients with febrile neutropenia at a tertiary care center. Asian Pac J Cancer Prev. 2017, 18:2741-5. 10.22034\/APJCP.2017.18.10.2741","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-023-00533-8","article-title":"Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania","volume":"18","author":"Safari LC","year":"2023","unstructured":"Safari LC, Mloka D, Minzi O, Dharsee NJ, Reuben R. Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania. Infect Agent Cancer. 2023, 18:52. 10.1186\/s13027-023-00533-8","journal-title":"Infect Agent Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5045\/br.2021.2021058","article-title":"Induction-related mortality in adolescents and young adults with acute lymphoblastic leukemia in a resource-limited setting: do treatment-related complications create more impact than disease biology?","volume":"57","author":"Inclan-Alarcon SI","year":"2022","unstructured":"Inclan-Alarcon SI, Riviello-Goya S, Teran-De-la-Sancha K, Fierro-Angulo OM, Acosta-Medina AA, Demichelis-Gomez R, Bourlon C. Induction-related mortality in adolescents and young adults with acute lymphoblastic leukemia in a resource-limited setting: do treatment-related complications create more impact than disease biology?. Blood Res. 2022, 57:29-33. 10.5045\/br.2021.2021058","journal-title":"Blood Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO Clinical Practice Guidelines","volume":"27","author":"Klastersky J","year":"2016","unstructured":"Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2016, 27:v111-8. 10.1093\/annonc\/mdw325","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/2049936113475610","article-title":"Management of febrile neutropenia in the era of bacterial resistance","volume":"1","author":"Alp S","year":"2013","unstructured":"Alp S, Akova M. Management of febrile neutropenia in the era of bacterial resistance. Ther Adv Infect Dis. 2013, 1:37-43. 10.1177\/2049936113475610","journal-title":"Ther Adv Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00269","article-title":"Optimal management of neutropenic fever in patients with cancer","volume":"15","author":"Zimmer AJ","year":"2019","unstructured":"Zimmer AJ, Freifeld AG. Optimal management of neutropenic fever in patients with cancer. J Oncol Pract. 2019, 15:19-24. 10.1200\/JOP.18.00269","journal-title":"J Oncol Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab624","article-title":"Safety and efficacy of antibiotic de-escalation and discontinuation in high-risk hematological patients with febrile neutropenia: a single-center experience","volume":"9","author":"Verlinden A","year":"2022","unstructured":"Verlinden A, Jansens H, Goossens H, Anguille S, Berneman ZN, Schroyens WA, Gadisseur AP. Safety and efficacy of antibiotic de-escalation and discontinuation in high-risk hematological patients with febrile neutropenia: a single-center experience. Open Forum Infect Dis. 2022, 9:ofab624. 10.1093\/ofid\/ofab624","journal-title":"Open Forum Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1078155215597558","article-title":"Evaluation of empiric antibiotic de-escalation in febrile neutropenia","volume":"22","author":"Kroll AL","year":"2016","unstructured":"Kroll AL, Corrigan PA, Patel S, Hawks KG. Evaluation of empiric antibiotic de-escalation in febrile neutropenia. J Oncol Pharm Pract. 2016, 22:696-701. 10.1177\/1078155215597558","journal-title":"J Oncol Pharm Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2015.1060576","article-title":"Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms","volume":"8","author":"Nou\u00e9r SA","year":"2015","unstructured":"Nou\u00e9r SA, Nucci M, Anaissie E. Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms. Expert Rev Hematol. 2015, 8:647-58. 10.1586\/17474086.2015.1060576","journal-title":"Expert Rev Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024883","article-title":"Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia","volume":"100","author":"Wang Y","year":"2021","unstructured":"Wang Y, Du Z, Chen Y, Liu Y, Yang Z. Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia. Medicine (Baltimore). 2021, 100:e24883. 10.1097\/MD.0000000000024883","journal-title":"Medicine (Baltimore)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2020.09.001","article-title":"Infectious disease complications in patients with cancer","volume":"37","author":"Seo SK","year":"2021","unstructured":"Seo SK, Liu C, Dadwal SS. Infectious disease complications in patients with cancer. Crit Care Clin. 2021, 37:69-84. 10.1016\/j.ccc.2020.09.001","journal-title":"Crit Care Clin"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/223353-survivorship-struggles-navigating-etiologies-and-clinical-parameters-of-febrile-neutropenia-during-induction-chemotherapy-in-acute-leukemia-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T12:40:34Z","timestamp":1708951234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/223353-survivorship-struggles-navigating-etiologies-and-clinical-parameters-of-febrile-neutropenia-during-induction-chemotherapy-in-acute-leukemia-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.54935","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,26]]}}}